HF
IRON icon

HRT Financial’s Disc Medicine IRON Stock Holding History

HRT Financial’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,358
Closed -$656K – 2932
2024
Q4 		$656K Buy
+10,358
New +$599K ﹤0.01% 1307
2024
Q1 		– Sell
-16,870
Closed -$974K – 2673
2023
Q4 		$974K Buy
+16,870
New +$864K 0.01% 998
2021
Q4 		– Sell
-1,385
Closed -$167K – 3605
2021
Q3 		$167K Buy
+1,385
New +$189K ﹤0.01% 2753

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial's IRON Position: Q1 2025 in Review

HRT Financial sold out of Disc Medicine (IRON) in Q1 2025, closing a stake of 10,358 shares — an estimated $656K sold.

HRT Financial first reported a position in IRON in Q3 2021 and held it in 3 quarters. The position peaked at $974K in Q4 2023. 157 funds tracked by Wall St. Rank hold IRON as of Q1 2025.

  • HRT Financial reported no remaining Disc Medicine position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 10,358 Disc Medicine shares in Q1 2025, an estimated $656K.
  • HRT Financial first reported a position in Disc Medicine in Q3 2021 and held it in 3 quarters.
  • HRT Financial's Disc Medicine position peaked at $974K in Q4 2023.
  • 157 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.